Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.

Authors
Publication date
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio Istituzionale della Ricerca - Università degli Studi di Pavia

    redirect
    oaioai:iris.unipv.it:11571/456848
    Last time updated on 03/09/2019